Clinical safety of tbo-filgrastim, a short-acting human granulocyte colony-stimulating factor
Crossref DOI link: https://doi.org/10.1007/s00520-015-3057-2
Published Online: 2016-01-16
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pettengell, Ruth
Bias, Peter
Mueller, Udo
Lang, Nicole
Funding for this research was provided by:
Teva Branded Pharmaceutical Products R&D, Inc.
Text and Data Mining valid from 2016-01-16